Adenomyosis and infertility. Management strategies
DOI: 10.32364/2618-8430-2021-4-2-110-114
A.E. Esedova, A.M. Medzhidova
Dagestan State Medical University, Makhachkala, Russian Federation
Aim: to improve the rate of pregnancy in women with adenomyosis and infertility.
Patients and Methods: this prospective comparative study included 150 women aged 24–38 years. Among them, 120 women were diagnosed with infertility and adenomyosis, and 30 healthy women planned pregnancy (control group). 60 women (study group 1) underwent surgery for adenomyosis, 30 women were followed up only (study subgroup 1A) and 30 women received Dienogest 2 mg for 6 months (study subgroup 1B). Women of study group 2 (n =60) underwent no surgery, 30 women were followed up only (study subgroup 2A) and 30 women received Dienogest 2 mg for 6 months (study subgroup 2B). After 3 and 6 months, blood levels of hormones, junctional zone thickness (measured by ultrasound), and the rate and time of pregnancy were assessed.
Results: at baseline, women with adenomyosis were reported to have high levels of estradiol (p<0.05 compared to the control group). After 3 and 6 months, the level of es tradiol gradually reduced to 432.5±27.4 pmole/l and 364.3±16.2 pmole/l in study subgroup 2A and 314.3±22.7 pmole/l and 264.7±18.6 pmole/l in study subgroup 2B (p<0.05). Pregnancy occurred, on average, after 6.1±1.6 (3–8) months in study subgroup 1A, 5.3±1.1 (4–7) months in study subgroup 2A, 4.1±1.4 (2–7) months in study subgroup 1B (p≤0.05 compared to study subgroup 1A and study group 2), and 5.1±1.2 (3–7) months in study subgroup 2B. In study groups 1 and 2, pregnancy occurred 1.5- and 1.4-times more commonly in women who received Dienogest.
Conclusions: surgery and further hormone therapy is an optimal management strategy for adenomyosis and infertility.
Keywords: adenomyosis, infertility, Dienogest, junctional zone, pregnancy.
For citation: Esedova A.E., Medzhidova A.M. Adenomyosis and infertility. Management strategies. Russian Journal of Woman and Child Health. 2021;4(2):110–114. DOI: 10.32364/2618-8430-2021-4-2-110-114.
About the authors:
Asiyat E. Esedova — Doct. of Sci. (Med.), professor of the Department of Obstetrics & Gynecology of the Pediatric, Dental, and Medical Preventive Faculties, Dagestan State Medical University; 1, Vi.I. Lenin sq., Makhachkala, 367012, Russian Federation; ORCID iD 0000-0002-9311-1791.
Aishat M. Medzhidova — postgraduate student of the Department of Obstetrics & Gynecology of the Pediatric, Dental, and Medical Preventive Faculties, Dagestan State Medical University; 1, Vi.I. Lenin sq., Makhachkala, 367012, Russian Federation; ORCID iD 0000-0003-4977-1183.
Contact information: e-mail: asholya2012@yandex.ru. Financial Disclosure: no authors have a financial or property interest in any material or method mentioned. There is no conflict of interests. Received 22.09.2020, revised 15.10.2020, accepted 09.11.2020.
2. Adamian L.V., Andreeva E.N. The role of hormone modulating therapy in the treatment of genital endometriosis. Russian Journal of Human Reproduction. 2011;17(6):66–77 (in Russ.).
3. Adamyan L.V., Andreeva E.N., Apolikhina I.A. and other Endometriosis: diagnosis, treatment and rehabilitation. Federal clinical guidelines for the management of patients. M.; 2013 (in Russ.).
4. Iarmolinskaia M.I., Florova M.S. The possibility of treatment with dienogest 2 mg in patients with genital endometriosis. Russian Journal of Human Reproduction. 2017;23(1):70–79 (in Russ.). DOI: 10.17116/repro201723170-79.
5. Abbott J., Hawe J., Hunter D. et al. Laparoscopic excision of endometriosis a randomized, placebo-controlled trial. Fertil Steril. 2014;82:878–884. DOI: 10.1016/j.fertnstert.2004.03.046.
6. Garcia-Velasco J.A., Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod. 2009;24(3):496–501. DOI: 10.1093/humrep/den398.
7. Parazzini F., Mais V., Cipriani S. et al. Determinants of adenomyosis in women who underwent hysterectomy for bening gynecological conditions: Result from a prospective multicentric study in Italy. Eur J Obstet Gynecol Reprod Biol. 2009;143(2):103–106. DOI: 10.1016/j.ejogrb.2008.12.010.
8. Dobrokhotova Yu.E., Kapranov S.A., Knysheva I.G. et al. The embolization of uterine arteries in obstetrics and gynecology. Medical Journal of the Russian Federation. 2014;20(1):42–47 (in Russ.).
9. Kunz G., Beil D., Huppert P. et al. Adenomyosis in endometriosis prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod. 2005;20:2309–2316. DOI: 10.1093/humrep/dei021.
10. Maubon A., Faury A., Kapella M. et al. Uterine junctional zone at magnetic resonance imaging: a predictor of in vitro fertilization implantation failure. J Obstet Gynaecol Res. 2010;36:611–618. DOI: 10.1111/j.1447-0756.2010.01189.x.
11. Ogorodnikov D.V., Ilyina I.Yu., Dobrokhotova Iu.Е. The effect of follicular high level progesterone on cycles of in vitro fertilization in protocols with antagonistsof gonadotropin-releasing hormone. Russian Journal of Human Reproduction. 2019;25(2):67–77 (in Russ.). DOI: 10.17116/repro20192502167.
12. Esedova A.E., Medzhidova A.M. Chronic pelvic pain with adenomyosis. Treatment methods. RMJ. 2021;4:44–47 (in Russ.).
This work is licensed under a Creative Commons «Attribution» 4.0 License.
